Simeon George is a partner at SROne, the VC arm of GlaxoSmithKline. He leads SR One’s investment activities on the West Coast. Prior to joining SR One, Simeon was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. Simeon received his BA in Neuroscience from the Johns Hopkins University, where he graduated Phi Beta Kappa. Simeon received his MD from the University of Pennsylvania School of Medicine and his MBA (Mayer Scholar) from the Wharton School of the University of Pennsylvania.